EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia

Krishna Adeshara, Elyse Di Marco, Marco Bordino, Daniel Gordin, Luciano Bernardi, Mark E Cooper, Per-Henrik Groop, FinnDiane Study Group

Cardiovascular Diabetology · 2024

DOI: 10.1186/s12933-024-02427-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Diabetology, 2024. Verfasst von Krishna Adeshara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, FIN-00290, Helsinki, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetic Nephropathies, Hyperglycemia, Oxidative Stress. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Helsinki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperglycemia-induced oxidative stress is a well-established pathological mediator of vascular complications in diabetes. We assessed plasma oxidant and antioxidant levels in response to acute and chronic hyperglycemia in relation to vascular stiffness and varying degrees of kidney disease in type 1 diabetes individuals.

Methods

The acute hyperglycemia study included 22 type 1 diabetic individuals with normal albumin excretion rate (AER) and 13 non-diabetic controls. These individuals received an acute glucose challenge during a 120-minute hyperglycemic clamp. The chronic hyperglycemia study included 118 type 1 diabetic individuals with chronically low ( n = 60) or high ( n = 58) HbA1c concentrations and varying degrees of diabetic kidney disease (DKD) classified as normal, moderate, or severe albuminuria (AER). Levels of malondialdehyde (MDA), reactive oxygen metabolites (ROMs), total antioxidant capacity (TAC), biological antioxidant potential (BAP) and superoxide dismutase (SOD) were measured from plasma or serum samples in the FinnDiane study.

Results

Levels of MDA ( p < 0.01) and ROMs ( p < 0.01) were elevated in type 1 diabetes individuals compared to non-diabetic controls at baseline. Acute hyperglycemia further increased MDA levels ( p < 0.05) and sustained the elevation of ROMs in type 1 diabetes individuals. Acute hyperglycemic challenge impaired TAC in both non-diabetic ( p < 0.05) and type 1 diabetes ( p < 0.01) individuals compared to baseline whereas BAP was increased ( p < 0.05) with no difference observed in non-diabetic controls. There was a positive association between high circulating MDA and AIx (r2 = 0.611, p = 0.05), and between delta ROMs and delta AIx (r2 = 0.955, p = 0.014) in combined analysis of individuals with type 1 diabetes and non-diabetic controls. Type 1 diabetes individuals with varying status of DKD, showed elevated levels of ROMs in those with high HbA1c compared to their counterpart with low HbA1c ( p < 0.05). Individuals with severe albuminuria showed elevated ROM levels ( p < 0.01) and depressed antioxidant capacity ( p < 0.01) compared to those with normal AER of comparable HbA1c concentrations.

Conclusions

Biomarkers of oxidative stress are associated with vascular stiffness and DKD following acute and chronic hyperglycemic exposure and may provide added value to HbA1c in understanding disease pathology, predicting risk and assessing the status of secondary complications of type 1 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetic NephropathiesHyperglycemiaOxidative StressAntioxidantsBiomarkersVascular StiffnessHumansMaleFemaleAdultCase-Control StudiesMiddle AgedBlood GlucoseMalondialdehydeGlycated HemoglobinReactive Oxygen SpeciesFinlandAcute DiseaseOxidantsAlbuminuriaSuperoxide DismutaseChronic Disease

Stichwörter der Autor:innen

Antioxidant capacityArterial stiffnessDiabetesDiabetic kidney diseaseHyperglycemiaOxidative stress

Substanzen

AntioxidantsBiomarkersBlood Glucosehemoglobin A1c protein, humanMalondialdehydeGlycated HemoglobinReactive Oxygen SpeciesOxidantsSuperoxide Dismutase

Autor:innen und Institutionen

  • Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, FIN-00290, Helsinki, Finland.
  • Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.
  • Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.

Förderung

  • University of Helsinki

Zitieren

APA

Adeshara, K., Di Marco, E., Bordino, M., Gordin, D., Bernardi, L., Cooper, M. E., Groop, P. H., & FinnDiane Study Group (2024). Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-024-02427-4

Vancouver

Adeshara K, Di Marco E, Bordino M, Gordin D, Bernardi L, Cooper ME, et al. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia. Cardiovascular Diabetology. 2024. doi:10.1186/s12933-024-02427-4

BibTeX
@article{Adeshara2024,
  author = {Adeshara, Krishna and Di Marco, Elyse and Bordino, Marco and Gordin, Daniel and Bernardi, Luciano and Cooper, Mark E and Groop, Per-Henrik and FinnDiane Study Group, FinnDiane Study Group},
  title = {Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia},
  journal = {Cardiovascular Diabetology},
  year = {2024},
  doi = {10.1186/s12933-024-02427-4}
}
Kostenlos starten →